Pregnancy outcome after early exposure to nivolumab, a PD-1 checkpoint inhibitor for relapsed Hodgkin's lymphoma.

Dear Editor,Nivolumab, a humanized IgG4 monoclonal antibody, blocks the programmed cell death protein-1 (PD-1) leading to lymphocyte activation against many chemotherapy-resistant tumors [1]. Women...